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Summary
Bacterial biofilms are thought to aid in the survivabil-
ity of a variety of intractable infections in humans.
Specifically, biofilm production in Pseudomonas aer-
uginosa has been shown to play a significant role in
chronic infection of cystic fibrosis (CF) patients. Un-
fortunately, no clinically effective inhibitors of biofilm
formation are available. A rapid screen of 4509 com-
pounds for nonantibiotic biofilm inhibitors in Pseu-
domonas aeruginosa PA14 was executed in 384-well
plates. Among those compounds, ferric ammonium
citrate inhibited biofilm formation in a dose-depen-
dent manner; other iron salts functioned similarly. In
addition to biofilm inhibition in static culture, pre-
grown biofilms could be disrupted and cleared by
switching to iron-rich media in flow-chamber experi-
ments. Furthermore, P. aeruginosa strains taken from
the sputum of 20 CF patients showed a similar re-
sponse to elevated iron levels. Previous expression-
profiling analyses demonstrated that high levels of
iron repress the expression of genes whose products
are essential for scavenging iron and that expression
of these genes is critical for virulence. Our results,
combined with existing transcriptional-profiling data,
now indicate that elevated iron concentrations re-
press the expression of certain genes essential for
biofilm production in P. aeruginosa.
Introduction
Pseudomonas aeruginosa is a gram-negative bacte-
rium responsible for infections that are the most fre-
quent cause of death in cystic fibrosis (CF) patients [1].
This pathogen possesses remarkable flexibility, flour-
ishing both independently in highly varied environ-
ments and as a parasite in other organisms. The adapt-
ability of P. aeruginosa stems in part from its propensity
for forming hearty, surface-associated, biocide-resis-
tant biofilms. P. aeruginosa is arguably the most
studied biofilm-forming bacteria, and its virulence and
persistence in infections of both CF patients and other
immunocompromised individuals is known to be aided
by biofilm production [2]. Highlighting the general im-
portance of biofilms in human health, recent estimates
indicate that biofilms account for over 80% of microbial
infections in the human body [3]. Because biofilms
show such recalcitrance toward antimicrobial treatment
[4–8], there is considerable interest in finding novel*Correspondence: hergenro@uiuc.edumethods for elimination of biofilm-producing patho-
gens. If compounds existed that killed biofilm bacteria
efficiently or disrupted existing biofilms, then biofilm-
utilizing pathogens would become much more clinically
manageable either by these new biofilm-tailored anti-
microbials alone or by the use of biofilm disruptors in
tandem with a traditional antibiotic.
Bacterial quorum sensing is known to be intimately
linked with virulence and biofilm production. Analogues
of N-acyl homoserine lactones, natural quorum-sens-
ing compounds in gram-negative bacteria such as
P. aeruginosa, have been found to inhibit biofilm pro-
duction in P. aeruginosa [9–11]. However, similar mole-
cules often agonize rather than ablate quorum sensing,
and the potencies and stabilities of N-acyl homoserine
lactones in aqueous conditions are nonoptimal [12].
Because there are few other examples of antibiofilm
compounds [13], the discovery of biofilm-specific anti-
microbials to contend with pathogenic, biofilm-forming
bacterial species is of particular importance. Herein, we
report the discovery that iron salts are efficient inhibi-
tors of biofilm formation in P. aeruginosa, disrupt pre-
formed biofilms, and prevent biofilm formation in P. aer-
uginosa strains taken from the sputum of CF patients.
This data serves to bolster a growing base of literature
linking iron availability with virulence-factor production
and biofilm formation in P. aeruginosa.
Results and Discussion
A microtiter plate-based assay was used to screen a
collection of small molecules (see http://scs.uiuc.edu/
wphgroup/comcollections.html for compound identi-
ties) for those that would specifically prevent or disrupt
biofilm formation in P. aeruginosa. Known protocols for
growing biofilms in 96-well plates [4, 10, 14–17] were
adapted and optimized for P. aeruginosa PA14 in a 384-
well plate format. In primary screening, P. aeruginosa
cells were grown in 384-well plates in the presence of
a functionally diverse collection of 4509 compounds.
After 48 hr growth time, plates were rinsed to remove
spent media, compounds, and planktonic cells, leaving
only biofilm bacteria. The remaining biofilms were
stained with 0.1% crystal violet stain and rinsed to re-
move unbound crystal violet dye. The biofilms of P. aer-
uginosa manifest themselves as rings formed at the
air-liquid interface of wells in the microtiter plate. As
adsorbed dye correlates directly to biofilm density, de-
sorption of the adhered stain in each well into acidic
solution allowed facile quantitation of biofilm in each
well in a microplate reader at 590 nm.
Each compound in the library was tested in triplicate
at 50 M final concentrations, and compounds that ex-
hibited at least 30% reduction in biofilm production
without inhibiting bacterial growth were classified as
“hits” in the primary assay. Control wells grown in the
absence of compounds typically displayed <6% rela-
tive standard deviation from well to well. Six com-
pounds (0.13% hit rate) were identified through this pri-
Chemistry & Biology
790mary screen that retarded biofilm production and gave s
hno growth inhibition by OD600. No compounds were
found to enhance biofilm production. These six com- i
spounds were retested for dose dependence with the
same microtiter-plate adherence assay, this time in a h
96-well format. From this testing, ferric ammonium cit-
rate (FAC) was found to provide reproducible and dose- n
bdependant inhibition of P. aeruginosa biofilm formation.
We were intrigued to find, in a library containing an i
tarray of drug-like molecules, that a simple ionic com-
pound showed moderate potency (IC50 z 60 M) in t
osuppressing biofilm production. Testing ammonium chlo-
ride, citric acid, ammonium citrate, and sodium citrate t
hin dose-dependence assays showed that neither am-
monium nor citrate ion were responsible for the inhibi- v
rtion. Conversely, when iron salts (ferric chloride, ferric
sulfate, ferrous sulfate) were examined, their effects t
imirrored that of FAC (Figure 1). FAC was also found to
exert its antibiofilm effects on glass surfaces (Figure d
s1, inset). Growth rates of P. aeruginosa PA14 were not
significantly affected over the range of 0–500 M iron a
a(Figure 2), and control 48 hr static cultures in polysty-
rene tubes at low and high iron show high and low r
tCFUs, respectively, of biofilm bacteria with plate counts
(data not shown), indicating that iron does not simply b
5interfere with CV staining of present biofilms. Based on
this evidence, we determined that iron itself was the
isource of the inhibition of biofilm production. Con-Figure 1. Dose Dependence of Iron Salts, Citrates, and Ammonium on 48 hr P. aeruginosa PA14 Biofilms
The amount of biofilm remaining was determined by the absorbance at 590 nm of the crystal violet dye. This dye is released into acidic
solution after plates are washed to remove planktonic cells; biofilm cells remain adherent and are stained. All readings are corrected to reflect
0% and 100% controls (blank well, 0%; biofilm growth without compounds present, 100%). Error bars represent the standard deviation from
the mean. Inset: static 48 hr PA14 cultures in glass at 0 and 200 M FAC also show that biofilm fails to form at high iron.idering that iron starvation (by lactoferrin chelation)
ad previously been found to inhibit biofilm production
n P. aeruginosa [18], we sought to corroborate this re-
ult with additional demonstrations of excess iron in-
ibiting P. aeruginosa biofilm production.
A marker signifying biofilm production in P. aerugi-
osa is the development of resistance to killing by anti-
iotics [18]. Static cultures of P. aeruginosa were grown
n 10 ml polystyrene culture tubes at varying concentra-
ions of FAC for 48 hr before treating with 60 g/ml of
he antibiotic tobramycin for 5 hr. This concentration
f antibiotic would destroy planktonic bacteria but not
hose that had formed biofilms [18]. At the end of the 5
r tobramycin treatment, the tubes were shaken and
ortexed to homogenize biofilms and planktonic bacte-
ia and then quickly diluted and plated onto fresh tryp-
ic soy agar (TSA) plates to assess survival of the cells
n each tube. Increased sensitivity to tobramycin was
isplayed as FAC concentration increased (Figure 3),
ubstantiating that FAC prevented biofilm formation in
dose-dependent manner. Control experiments in the
bsence of tobramycin showed no inhibition of bacte-
ial growth from 0–500 M FAC. No synergy was de-
ected between FAC and tobramycin; MIC tests of to-
ramycin on planktonic P. aeruginosa PA14 at 0 and
00 M FAC result in the same value of 1.2 g/ml.
Another common method for cultivating and examin-
ng biofilms is the use of a flow-chamber device. We
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791Figure 2. Growth Rate of P. aeruginosa PA14
in Varying Concentrations of Ferric Ammo-
nium Citrate
A culture of PA14 at OD600 = 0.5 was diluted
1:100 into T-broth media containing varying
iron. Cultures were shaken, and aliquots
were taken and measured at the time points
indicated. At 0 and 60 min, no significant dif-
ference from media blanks was observed.
Through CFU plate counts, we determined
that 3.5 × 108 CFU/ml corresponds to
OD600 z 1.mation and subsequent disruption of biofilm in the flow dose-dependent inhibition of biofilm formation was
Figure 3. The Effect of Ferric Ammonium Cit-
rate on Susceptibility of Static Cultures of
P. aeruginosa PA14 to Tobramycin
Cells were grown for 48 hr in a range of con-
centrations of ferric ammonium citrate (FAC)
in 10 ml polystyrene culture vials without
shaking. After 48 hr, tobramycin was added
to 60 g/ml final concentration in each vial
and allowed to incubate with the cells (with-
out shaking) for 5 hr. At the end of this incu-
bation, the tubes were shaken and vortexed
for 1 min to loosen adherent cells, and an
aliquot was quickly diluted with fresh T-broth
to 1:10,000–1:40,000. 10 l of these diluted
cultures were plated onto TSA (tryptic soy
agar) plates, and colonies were counted.
FAC itself (0–500 M) showed no inhibition
of bacterial growth. Controls in absence of
tobramycin treatment showed z200 × 106
CFU/ml from 0–500 M FAC (data not
shown), indicating that about 75% of the
biofilm bacteria survive the tobramycin
treatment.used a commercially available flow-channel device in
which biofilm grows on a microscope cover slip. Seeded
into the flow chamber and allowed to grow for 5 days
in 50% T-broth media under conditions of low flow (4
ml/h), P. aeruginosa PA14 formed robust biofilms that
were easily visualized by rinsing, heat fixing, and stain-
ing with crystal violet after disassembly of the flow
chamber (Figure 4A). 10-day biofilms grown in like man-
ner were similarly robust and easily visualized by fixing
and staining (Figure 4B). Conversely, attempts to culti-
vate biofilms in iron-rich media (50% T-broth + 200 M
FAC) produced no biofilm growth (Figure 4C). Further-
more, biofilms that were pregrown for 5 days without
iron supplementation to the media and then subjected
to 200 M FAC in 50% T-broth for 5 additional days
were completely cleared (Figure 4D). This experiment
suggested that disruption of pre-existing biofilm by
FAC had occurred.
P. aeruginosa PA14 was transformed with lac-con-
trolled eGFP plasmid pMRP-9 in order to observe for-chamber in a single unequivocal experiment [18]. When
grown in 50% T-broth containing 300 g/ml carbenicil-
lin for plasmid maintenance and 1 mM IPTG to ensure
eGFP expression, the growth and disruption of biofilm
could be monitored during flow by fluorescence
microscopy. Fluorescence images confirm that at 5
days (before addition of FAC), biofilm growth has pro-
ceeded readily, with confluent cell growth evident (Fig-
ure 5A). After 5 days, the chamber was fed with media
containing carbenicillin, IPTG, and 200 M FAC. At 8
days, it was unambiguous that disruption of the biofilm
had occurred (Figure 5B), and by day ten, the biofilm
was completely vanquished (Figure 5C).
Distinct clinical isolates of the organism from the
sputum of 20 CF patients at a local hospital were ob-
tained and tested for dose-dependent response to iron
in biofilm production to demonstrate iron’s ability to in-
hibit biofilm formation across multiple strains of P. aeru-
ginosa. Seventeen of these strains produced significant
biofilm in the microtiter plate test in 96-well plates, and
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792Figure 4. Macro- and Microscopic Pictures
of Standard Microscope Slide Used in Flow
Cell at Various Time Points
In all cases, the flow cell was disassembled
after the indicated time, and the slide was
stained with 0.1% crystal violet. (A) 5-day
biofilm growth control. A biofilm of P. aerugi-
nosa PA14 was grown in flow chamber with
50% T-broth growth media for 5 days. (B) 10-
day growth control. A biofilm of P. aerugi-
nosa PA14 was grown in flow chamber with
50% T-broth growth media for 10 days. (C)
Ferric ammonium citrate (FAC) prevents the
formation of biofilms. The flow cell was inoc-
ulated with PA14 and maintained (4 ml/hr) for
5 days in 50% T-broth + 200 M FAC. (D)
FAC causes the disruption of existing bio-
films. PA14 biofilm was grown for 5 days in
50% T-broth, and then the media feeding the
cell was switched to 50% T-broth + 200 M
FAC and grown an additional 5 days. All mi-
croscopic pictures are 400× magnification.paired because biofilms at 0 and 250 M iron are virtu-P. aeruginosa PA14 biofilm inhibition was monitored
Figure 5. Pregrown Biofilms Are Disrupted by Ferric Ammonium Citrate
(A) P. aeruginosa PA14 harboring the plasmid pMRP-9 was grown for 5 days in the flow-cell chamber. The biofilm formed under these
conditions (50% T-broth, 300 g/ml carbenicillin for plasmid maintenance, 1 mM IPTG for eGFP induction, flow rate = 4 ml/hr) was visualized
by fluorescence microscopy.
(B) At this point, 200 M ferric ammonium citrate (FAC) was added to the media, and flow was continued through the chamber for 3 more
days. Partial disruption of the biofilm at this day eight time point was visualized by fluorescence microscopy.
(C) Complete disruption of the PA14 biofilm was observed at day ten. Subsequent flow-cell disassembly and staining of the microscope slide
(with crystal violet) after this day-ten time point confirmed the lack of biofilm (not shown). All pictures are 400× magnification and are
representative of several locations in the center of the flow channel.clearly evident in a vast majority of these strains (data a
(not shown). 14 of the 17 strains (82%) displayed >40%
inhibition of biofilm production by 250 M FAC, and 7 u
tout of 17 (41%) revealed >80% inhibition (Figure 6). As
indicated in the figure legend for Figure 6, many of t
tthese isolates were mucoid, and all isolates showed
similar doubling times. 4s a function of time at low (0 iron added) and high
250 M iron added) concentrations of FAC to further
nderstand how iron might be affecting biofilm forma-
ion (Figure 7A). This assay was performed identically
o the secondary screen for dose dependence except
hat plates were examined at varying times from 0 to
8 hr. This data shows that initial attachment is not im-
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793Figure 6. Effects of 250 M Ferric Ammo-
nium Citrate on Clinical Isolates of P. aeru-
ginosa
Ferric ammonium citrate’s (FAC) effects were
measured for 20 P. aeruginosa samples iso-
lated from the sputum of CF patients at Carle
Foundation Hospital (Urbana, IL). The bacte-
ria were grown for 48 hr in T-broth + 250 M
FAC. The amount of biofilm formed was
graphed relative to controls where no FAC
had been added. Three of the 20 isolates
produced no biofilm in the assay. Among the
biofilm-producing strains, isolates 1, 2, 3, 4,
5, 6, 10, 12, 15, and 16 were determined to
be mucoid by visual inspection on TSA and
blood agar plates. Each strain had a dou-
bling time between 15 and 60 min, and all
grew to stationary phase within 24 hr in
shaken cultures at 37°C (data not shown).completely vanquished (as seen in earlier dose-depen-
Figure 7. Mechanistic Implications of Iron Effects on Biofilm Pro-
duction
(A) Time course of P. aeruginosa PA14 biofilm production in micro-
titer plates was monitored at 0 and 250 M iron in T-broth media.
At 18 and 24 hr time points, biofilm production is stalled in 250 M
iron compared to 0 M, and by 48 hr, disruption is nearly quanti-
tative.
(B) Twitching motility of P. aeruginosa PA14 in varying iron concen-
trations. TSA plates with 1% agar were used to assess twitching
motility. As the concentration of FAC increases, twitching motility
decreases significantly. Error bars on both graphs represent one
standard deviation from the mean.ally identical at 10 hr. After initial biofilm formation,
however, iron powerfully disrupts the process of biofilm
formation; biofilms at 48 hr in 250 M iron are almostdence experiments monitored after 48 hr biofilm growth).
Also, twitching motility has been shown to be vital to
the process of biofilm formation in P. aeruginosa [19].
Twitching motility was assessed in varying iron concen-
trations as previously performed [20]. Stab cultures on
TSA plates with 1% agar showed impaired twitching at
elevated iron concentrations at 24 hr (Figure 7B).
This study gives ample evidence supporting the im-
portance of iron as it relates to biofilm formation in
P. aeruginosa. Singh and coworkers showed that in the
virtual absence of iron (because of chelation by lacto-
ferrin), Pseudomonas cannot form biofilms [18]. Indeed,
lactoferrin also inhibited biofilm formation in our static
culture dose-dependence assays (data not shown),
presumably by starving the bacteria of iron required for
biofilm formation. Our findings have revealed that ex-
cess iron has the same biofilm-inhibiting effect, indicat-
ing that biofilm formation in P. aeruginosa is optimal
over a limited range of iron concentrations (from z1–
100 M), above and below which the organism can ex-
ist only in a planktonic state.
The effectiveness of FAC in inhibiting biofilm growth
in a majority of these clinical isolates of P. aeruginosa
naturally arouses curiosity about a possible role for iron
in the treatment of CF. In most cases, the use of iron
to improve the course of bacterial infections has been
discouraged because lack of iron is often a growth-lim-
iting factor for bacterial growth in vivo [21]. Further-
more, a mutant of P. aeruginosa PAO1 deficient in
producing the iron-chelating siderophore pyoverdin
grew poorly in an immunosuppressed mouse infection
model, demonstrating the importance of iron acquisi-
tion to functional pathogenesis [22]. These observa-
tions affirm the absolute requirement of iron for the
growth of most bacterial species. However, a direct and
provocative correlation is seen between iron deficiency
in CF patients and severity of lung infection by P. aeru-
ginosa [23], suggesting that a simplistic view equating
iron availability with bacterial pathogenesis belies a
more complex truth. In fact, in vitro growth experiments
approximating conditions of the human lung showed
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high-iron conditions [24]. Given that iron disrupts bio- r
films in vitro in a large percentage of clinical isolates of t
P. aeruginosa and that precedent exists for high con-
centrations of medication to be used through direct in- S
troduction to the CF lung (many CF patients inhale
doses of tobramycin that would be acutely toxic if ad- B
ministered systemically), further investigations of the f
feasibility of nebulized iron treatment in the CF lung are n
warranted. There is some precedent for the use of met- f
als for the treatment of specific disorders (i.e., lithium (
treatment for bipolar disorder), and, thus, a fair body d
of information about delivery strategies for metals is p
available [25]. l
Not surprisingly, two transcriptional profiling studies f
indicate that iron limitation induces the expression of m
many genes involved in iron acquisition [26, 27]: high u
iron concentrations (100–200 M) repress a number of p
genes involved in iron acquisition. Many of these genes f
are involved in the biosynthesis of two key sidero- t
phores, pyochelin and pyoverdin, that are implicated in d
scavenging iron, including the gene controlling pyover- b
din biosynthesis, pvdS. t
Interestingly, in P. aeruginosa, there is a direct corre- f
lation between the expression of iron acquisition genes e
and virulence-factor production and pathogenesis. For a
example, in addition to its role in scavenging iron, p
secreted pyoverdin signals for the production of viru- t
lence factors that are critical to the ability of this patho- t
gen to cause disease [28]. Transcription of pvdS is di- t
rectly regulated by iron levels; thus, the PvdS protein is p
only synthesized (and, hence, pyoverdin is only pro- b
duced) under conditions of iron starvation [26, 28]. Al-
n
though not without controversy, evidence indicates that flow levels of free iron in the lung are important for pP. aeruginosa virulence in CF [23, 24, 29–31]. iAmong the most important virulence factors in P. aer-
uginosa, and the one actively investigated in this manu- E
script, is the formation of biofilms [32]. Biofilm forma-
tion is a complex process of differentiation in which B
many changes in gene expression occur [5, 6]. Many of P
Hthese changes have been shown to be mediated
cthrough quorum sensing, a positive-feedback process
oin which secreted signaling molecules called AHLs
U(n-Acyl Homoserine Lactones) are monitored by the
l
bacteria as a sensitive measure of their localized pop- p
ulation density [33–35]. Specifically, P. aeruginosa uses t
3-oxo-dodecanoyl homoserine lactone and butyl ho- w
moserine lactone as its primary and secondary quo-
rum-sensing signals. At sufficient population density 3
T(and corresponding AHL concentrations), the quorum
ssensing system directs P. aeruginosa to form biofilms.
IIntriguingly, the quorum sensing system itself is sub-
h
ject to some degree of regulation by iron concentration. w
Gene microarray studies have shown that the mRNA of P
MvfR, a protein required for synthesis of adequate p
levels of 3-oxo-dodecanoyl homoserine lactone (the T
pprimary AHL signal in P. aeruginosa) is repressed
lconsiderably in iron-replete compared to iron-limited
wgrowth conditions [26]. Thus, mvfR can function as an
n
iron-sensitive trigger to modulate quorum sensing in n
P. aeruginosa and, by so doing, can inhibit production t
of bacterial biofilms. Of course, genetic control of bio- w
ofilm formation, virulence, and iron acquisition are com-lex, interlinked, and poorly characterized. Other iron-
egulated mechanisms [36, 37] could well be important
o biofilm formation in P. aeruginosa.
ignificance
iofilms play an important role in most bacterial in-
ections of the human body. Particularly, Pseudomo-
as aeruginosa uses biofilms to evade immune de-
enses and exert its pathogenesis in cystic fibrosis
CF) patients. Precious few compounds have been
eveloped that target biofilm bacteria, and these com-
ounds have potency and stability problems that will
ikely preclude any eventual clinical application. A
acile screen to test putative inhibitors of biofilm for-
ation in P. aeruginosa PA14 has been developed and
sed to screen a collection of 4509 diverse com-
ounds in search of potent modulators of biofilm
ormation. It was determined that ferric ammonium ci-
rate (FAC) inhibited biofilm formation in a dose-
ependent fashion and disrupted previously formed
iofilms in flow-channel experiments. Through addi-
ional testing on strains of Pseudomonas aeruginosa
rom CF patients, iron’s effects were found to be gen-
ral: 14 of 17 strains that formed significant biofilm
lso displayed a dose-dependent decrease of biofilm
roduction in response to FAC. These results add to
he mounting evidence indicating that iron levels dic-
ate virulence of P. aeruginosa: extreme iron starva-
ion (through total chelation of iron) inhibits biofilm
roduction, moderate iron concentrations allow for
iofilm production and are critical for virulence, and
ow we show that high concentrations of iron power-
ully inhibit biofilm production, likely through the re-
ression of various genes involved in iron scaveng-
ng and quorum sensing.
xperimental Procedures
acterial Strains and Plasmids
. aeruginosa PA14 was a kind gift of Professor Roberto Kolter,
arvard Medical School. Plasmid pMRP-9, which carries carbeni-
illin resistance and lac-inducible eGFP expression, was a kind gift
f Professor E.P. Greenberg, Department of Microbiology at the
niversity of Iowa. The 20 P. aeruginosa clinical strains were col-
ected from the sputum of 20 CF patients at Carle Foundation Hos-
ital in Urbana, Illinois. Each strain was subcultured twice on tryp-
ic soy agar (TSA) plates and stored as a glycerol stock. The strains
ere given the arbitrary designations CI1-CI20.
84-Well Plate Screen for Biofilm Inhibition
he 4509 compounds screened were collected from a variety of
ources within the Department of Chemistry at the University of
llinois; the full list of compounds with structures can be viewed at
ttp://scs.uiuc.edu/wphgroup/comcollections.html. All compounds
ere arrayed in 384-well plates as 10 mM stock solutions in DMSO.
. aeruginosa PA14 was grown in T-broth (10 g tryptone, 5 g NaCl
er liter) to a OD600 of 0.8 and diluted by a factor of 40 with fresh
-broth media. 100 l of this diluted bacterial suspension was
laced in each well of the first 23 columns of a 384-well plate,
eaving the final column for control wells. Half of the control wells
ere filled with the bacterial suspension as positive controls with
o compound treatment, and the other eight were left empty as a
egative control for the staining procedure. Using a 384-well pin
ransfer device (V & P Scientific, San Diego CA), we transferred
0.25 l of the compounds from the compound plate into the wells
f dilute bacterial suspension (the 24th column in the compound
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795plates was left without compounds to correspond to the experi-
mental control wells). Compounds were pin transferred into each
plate two times to reach 50 M concentration. The library was
screened in triplicate by this procedure.
Plates were incubated in a humidified chamber at 37°C for 48 hr
and then examined via a multiwell plate reader at OD600. Wells that
showed no turbidity were classified as antibiotics and dismissed
from further analysis as biofilm disruptors. After noting all antibiot-
ics, the plates were gently rinsed under lukewarm tap water to re-
move planktonic and loosely adherent organisms. The plates were
then shaken dry and each well of each plate stained with 110 l of
a 0.1% crystal violet solution in water. After allowing the stain to
adhere to the biofilms for 5 min, each plate was again rinsed gently
under lukewarm water until no more stain could be rinsed from the
plate. Each plate was again shaken dry, inverted, and allowed to
dry thoroughly for 15 min. Finally, 120 l of a 30% acetic acid solu-
tion was pipetted into each well to desorb the adhered stain back
into solution. After allowing 30 min for the adhered stain to dissolve
into the destaining solution, the biofilm in each well was quantified
by reading the absorbance of the plates at 590 nm. A similar pro-
cedure, scaled up, was used to test the glass vials as substrates
for biofilm inhibition, with the same dilute bacterial suspension be-
ing utilized.
Dose-Dependent Effect of Iron Salts on P. aeruginosa
A similar method was used to test dose dependence of iron salts
and controls in 96-well plates. Bacteria were grown and diluted as
above, and 150 l dilute bacterial suspension was placed in each
well of a 96-well plate (except the final column, again reserved for
positive and negative controls). Compounds were added to the
wells via multichannel pipette as serial dilutions. The bacteria were
grown for 48 hr and analyzed similarly, with 160 l CV stain per well
and 180 l 30% acetic acid per well for the destaining/quantitation
step. Strains of P. aeruginosa isolated from the sputum of CF pa-
tients were analyzed in an identical fashion.
Susceptibility of P. aeruginosa to Tobramycin in Varying [FAC]
P. aeruginosa PA14 were grown to OD600 = 0.8 and diluted 1:40 into
10 ml plasic tissue culture vials, 2 ml per vial. FAC was added to
each dilute culture to the desired concentration. The cultures were
grown for 48 hr at 37°C without shaking. After 48 hr, tobramycin
was added to 60 g/ml total concentration in each vial, and each
was left undisturbed for 5 hr. After 5 hr, vials were vortexed and
shaken to homogenize cultures and aliquots quickly diluted and
plated onto TSB agar plates to count remaining viable bacterial
colony forming units (CFU).
Flow-Cell Experiments
P. aeruginosa PA14 was grown overnight to stationary phase
(OD600 = 1–3) in T-broth media to visualize the effects of FAC on
flow-cell biofilms. About 5 ml of this culture was used to fill the
flow cell (BioSurface Technologies Corporation, FC81 flow cell with
Fisherbrand variable-flow peristaltic pump) via sterile syringe, and
the culture was left in the cell without flow for 90 min. At this time,
50% T-broth media was flowed through the chamber at 4 ml/hr.
After 5 days (Figure 4A) or 10 days (Figure 4B), the flow cell was
disassembled and the standard microscope slide that forms one of
the walls of the flow chamber was rinsed gently but thoroughly
under lukewarm tap water, heat fixed, and stained for 1 min with
0.1% crystal violet stain. Excess stain was rinsed away, and the
slide was shaken dry before light microscopy and photographs
were recorded. The same protocol was employed for experiments
utilizing 50% T-broth, 200 M FAC (Figure 4C). For the biofilm dis-
ruption experiment (Figure 4D), the media was changed after 5
days to 50% T-broth, 200 M FAC. After 5 more days, the flow cell
was disassembled, and the slide was stained as above.
P. aeruginosa PA14 was transformed with pMRP-9 to directly vi-
sualize the formation and disruption of biofilms within the flow-cell
chamber. PA14-pMRP-9 were grown overnight to stationary phase
(OD600 = 1–3) in T-broth media supplemented with 300 g/ml car-
benicillin. Approximately 5 ml of this culture was used to fill the
flow cell via sterile syringe, and the culture was left in the cell with-
out flow for 1.5 hr. At this time, media flow (50% T-broth, 300 g/ml carbenicillin, 1 mM IPTG) was begun through the chamber at a
rate of 4 ml/hr. As described in the text and legend for Figure 5,
after 5 days, the chamber was examined microscopically with an
Axiovert model fluorescence microscope. At this point, the media
was changed to 50% T-broth, 300 g/ml carbenicillin, 1 mM IPTG,
and 200 M FAC, the flow was continued, and the cell was moni-
tored by fluorescence microscopy after 3 and 5 more days.
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